Correlation between ErbB2 expression and survival rates of osteosarcoma patients

Medical Journal of Wuhan University

Volumn 35, Issue 2, 2014, Pages 273-276

  Lu, Biao ^a  

^a Dept of Obstetrics and Gynecology   (China)

Author keywords

C erbB2; ErbB2 protein; Osteosarcoma

Indexed keywords

EID: 84902592862     PISSN: 16718852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Ritter J, Bielack S S. Osteosarcoma[J]. Ann Oncol, 2010, 21(Suppl 7): vii320-vii325.
2. Balamuth N J, Womer R B. Ewing's sarcoma[J]. Lancet Oncol, 2010, 11: 184-192.
3. Hughes D P, Thomas D G, Giordano T J, et al. Essential erbB family phosphorylation in osteosarcoma as a target for CI-1033 inhibition[J]. Pediatr Blood Cancer, 2006, 46(5): 614-623.
4. Akatsuka T, Wada T, Kokai Y, et al. Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma[J]. Oncology, 2001, 60: 361-366.
5. Muss H B, Thor A D, Berry D A, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer[J]. N Engl J Med, 1994, 330: 1260-1266.
6. Onda M, Matsuda S, Higaki S, et al. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma[J]. Cancer, 1996, 77: 71-78.
7. Gorlick R, Huvos A G, Heller G, et al. Expression of HER2/erbB-2 correlates with survival in osteosarcoma[J]. J Clin Oncol, 1999, 17: 2781-2788.
8. Guinee D G Jr, Travis W D, Trivers G E, et al. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression[J]. Carcinogenesis, 1995, 16: 993-1002.
9. Ebb D, Meyers P, Grier H, et al. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group[J]. J Clin Oncol, 2012, 30(20): 2545-2551.